Geode Capital Management’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Buy |
|
|||||
|
2025
Q1 | $36.9K | Buy |
|
|||||
|
2024
Q4 | $77.6K | Sell |
|
|||||
|
2024
Q3 | $103K | Buy |
|
|||||
|
2024
Q2 | $27.7K | Buy |
|
|||||
|
2024
Q1 | $13.1K | Hold |
|
|||||
|
2023
Q4 | $17.1K | Hold |
|
|||||
|
2023
Q3 | $30.3K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $43K | Buy |
|
|||||
|
2022
Q1 | $54K | Hold |
|
|||||
|
2021
Q4 | $154K | Buy |
|
|||||
|
2021
Q3 | $238K | Buy |
|
|||||
|
2021
Q2 | $235K | Buy |
|
|||||
|
2021
Q1 | $193K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $14K | Hold |
|
|||||
|
2020
Q2 | $16K | Hold |
|
|||||
|
2020
Q1 | $10K | Hold |
|
|||||
|
2019
Q4 | $24K | Hold |
|
|||||
|
2019
Q3 | $45K | Buy |
|